A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone.

Julie N GraffTomasz M BeerJoshi J AlumkalRachel E SlottkeWilliam L RedmondGeorge V ThomasReid F ThompsonMary A WoodYoshinobu KoguchiYiyi ChenEmile LatourRaymond C BerganCharles G DrakeAmy E Moran

Published in: Journal for immunotherapy of cancer (2021)

clinicaltrials.gov (NCT02312557).

Keyphrases

phase ii
prostate cancer
clinical trial
open label
squamous cell carcinoma
small cell lung cancer
randomized controlled trial
double blind
middle aged
placebo controlled
study protocol